There are a few new drugs out there that can actually slow down Alzheimer’s disease. But, by the time around half of Americans get…
Inside every cell in the body, smaller structures called mitochondria turn sugary fuel into energy. Nicotinamide adenine dinucleotide (NAD) is the universal energy currency…
Is the fountain of youth really filled with Red Bull? Yes, according to some news headlines. “Common energy drink ingredient taurine ‘may slow aging…
A new way of defining for Alzheimer’s could help patients receive an early and accurate diagnosis. Clinicians presented a draft of a new definition…
According to the CDC, about 25 million Americans have high levels of cholesterol. Another 86 million people have elevated levels considered borderline high. Cholesterol…
One day, Don Kent’s personality started changing. A cool, even-keeled lawyer, he found himself suddenly losing control of his emotions. At the same time,…
Dementia is most widely associated with its cognitive symptoms, like memory loss. But it often brings a host of behavioral symptoms, too, like agitation…
If you could get a $400 blood test that tells you within 10 days whether you’re likely to develop Alzheimer’s disease years or decades…
Beta-amyloid plaques — sticky globs of protein — build up in the brains of people with Alzheimer’s disease. For decades, scientists have focused on…
Vaccines are one of the greatest medical advances in history, and now, this strategy is being applied to the treatment and prevention of Alzheimer’s….
Depression is a common mood disorder that can make people feel persistently sad or hopeless, extremely fatigued, and cause them to lose joy in…
More than one in four adults over the age of 65 develops diabetes. This condition damages the pancreas, making it hard for the body…
About 1.7 million Americans have taken up use of a substance called kratom — an herbal extract from the leaves of a tropical tree…
Right now, a definitive Alzheimer’s diagnosis can only be obtained through the detection of beta-amyloid levels in the brain — clumps of a protein…
In January of 2023, the Food and Drug Administration approved the second anti-amyloid therapy for Alzheimer’s disease, Leqembi (generic name lecanemab). A new Alzheimer’s…